Enveric Biosciences (ENVB) Non-Current Assets (2011 - 2026)
Enveric Biosciences (ENVB) posted Non-Current Assets of $150,674 for Q2 2026, down 37.5% from $241,082 a year earlier but up 2.9% from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) Non-Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Enveric Biosciences' Non-Current Assets came in at $159,234, down 54.2% from FY2024.
- Annual Non-Current Assets has declined for four consecutive years, with a five-year compound annual growth rate of -38.6% (FY2020 to FY2025).
- In prior years, Enveric Biosciences' Non-Current Assets was $347,959 in FY2024 (-51.6%), $718,309 in FY2023 (-35.9%), $1.12 million in FY2022 (-87.5%) and $8.98 million in FY2021 (+394.2%).
- Quarterly Non-Current Assets has run from a low of $146,365 in Q1 2026 to a high of $47.48 million in Q3 2021 over five years.
- On a year-over-year basis, Non-Current Assets has declined in each of the last 16 quarters, with an average decline of 50.0% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q4 2021, with growth of 394.2%; the weakest was Q3 2023, with a decline of 90.8%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $146,365 (Q1 2026), $159,234 (Q4 2025) and $196,521 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Enveric Biosciences | 6.02 Mn | -15.62 Mn | - | 150,674.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 150,674.00 |
| Mar 31, 2026 | 146,365.00 |
| Dec 31, 2025 | 159,234.00 |
| Sep 30, 2025 | 196,521.00 |
| Jun 30, 2025 | 241,082.00 |
| Mar 31, 2025 | 267,279.00 |
| Dec 31, 2024 | 347,959.00 |
| Sep 30, 2024 | 452,057.00 |
| Jun 30, 2024 | 531,670.00 |
| Mar 31, 2024 | 620,972.00 |
| Dec 31, 2023 | 718,309.00 |
| Sep 30, 2023 | 792,272.00 |
| Jun 30, 2023 | 900,151.00 |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 1.12 Mn |
| Sep 30, 2022 | 8.59 Mn |
| Jun 30, 2022 | 9.20 Mn |
| Mar 31, 2022 | 9.51 Mn |
| Dec 31, 2021 | 8.98 Mn |
| Sep 30, 2021 | 47.48 Mn |
API Access
Enveric Biosciences Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();